bpc 157 peptide human clinical trials safety BPC-157 FDA Approval Status: Is It Approved for Use? BPC-157 – Research Peptide |

Call your doctor without delay if you develop the following symptoms: nausea, vomiting, restlessness, agitation, confusion, delirium, fast or irregular heartbeat, dilated pupils, muscle twitching or rigidity, fever, and high blood pressure

Some people may experience temporary redness, swelling, or irritation at the injection site, while others might notice changes in appetite, water retention, joint aches, or mild fatigue

& Rajamma, U

Because AOD-9604 does not suppress appetite mechanisms in the first place, there is no adaptation of hunger-regulating neurons and no compensatory hunger amplification when the peptide is stopped